Total Clarity Wealth Management’s Mereo BioPharma MREO Stock Holding History

Total Clarity Wealth Management’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-11,860	Closed	-$39.1K	–	280
2024 Q1	$39.1K	Buy	+11,860	New	+$40.1K	0.01%	264
2022 Q3	–	Sell	-2,000	Closed	-$2K	–	690
2022 Q2	$2K	Buy	+2,000	New	+$1.55K	﹤0.01%	936
2022 Q1	–	Sell	-2,000	Closed	-$3K	–	638
2021 Q4	$3K	Sell	2,000 -375	-16%	-$750	﹤0.01%	882
2021 Q3	$6K	Buy	+2,375	New	+$6.29K	﹤0.01%	786
2021 Q2	–	Sell	-2,150	Closed	-$7K	–	525
2021 Q1	$7K	Buy	+2,150	New	+$7.6K	﹤0.01%	623

Other funds holding MREO

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return

Total Clarity Wealth Management's MREO Position: Q2 2024 in Review

Total Clarity Wealth Management sold out of Mereo BioPharma (MREO) in Q2 2024, closing a stake of 11,860 shares — an estimated $39.1K sold.

Total Clarity Wealth Management first reported a position in MREO in Q1 2021 and held it in 5 quarters. The position peaked at $39.1K in Q1 2024. 79 funds tracked by Wall St. Rank hold MREO as of Q2 2024.

Total Clarity Wealth Management reported no remaining Mereo BioPharma position as of Q2 2024 after selling out during the quarter.
Total Clarity Wealth Management sold 11,860 Mereo BioPharma shares in Q2 2024, an estimated $39.1K.
Total Clarity Wealth Management first reported a position in Mereo BioPharma in Q1 2021 and held it in 5 quarters.
Total Clarity Wealth Management's Mereo BioPharma position peaked at $39.1K in Q1 2024.
79 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2024.

Based on Total Clarity Wealth Management's 13F filing for Q2 2024, filed 9 Aug 2024.